These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 33309274)

  • 21. Artificial feeder cells expressing ligands for killer cell immunoglobulin-like receptors and CD94/NKG2A for expansion of functional primary natural killer cells with tolerance to self.
    Michen S; Frosch J; Füssel M; Schackert G; Momburg F; Temme A
    Cytotherapy; 2020 Jul; 22(7):354-368. PubMed ID: 32451262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expansion of umbilical cord blood mononuclear cell-derived natural killer cells dependent on the dose of interleukin-15 with Flt3L.
    Nagamura-Inoue T; Mori Y; Yizhou Z; Watanabe N; Takahashi TA
    Exp Hematol; 2004 Feb; 32(2):202-9. PubMed ID: 15102482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of porcine natural killer cells and lysis of foot-and-mouth disease virus infected cells.
    Toka FN; Nfon CK; Dawson H; Estes DM; Golde WT
    J Interferon Cytokine Res; 2009 Mar; 29(3):179-92. PubMed ID: 19196070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple effects of IL-21 on human NK cells in ex vivo expansion.
    Li Q; Ye LJ; Ren HL; Huyan T; Li J; Shi JL; Huang QS
    Immunobiology; 2015 Jul; 220(7):876-88. PubMed ID: 25758713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lower concentrations of methyl-β-cyclodextrin combined with interleukin-2 can preferentially induce activation and proliferation of natural killer cells in human peripheral blood.
    Lü HZ; Zhu AY; Chen Y; Tang J; Li BQ
    Hum Immunol; 2011 Jul; 72(7):538-46. PubMed ID: 21540068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-vitro activation of natural killer cells from regional lymph nodes of melanoma patients with interleukin-2 and interleukin-15.
    Vuletić AM; Jovanić IP; Jurišić VB; Milovanović ZM; Nikolić SS; Tanić NT; Konjević GM
    Melanoma Res; 2015 Feb; 25(1):22-34. PubMed ID: 25380182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their
    Heinze A; Grebe B; Bremm M; Huenecke S; Munir TA; Graafen L; Frueh JT; Merker M; Rettinger E; Soerensen J; Klingebiel T; Bader P; Ullrich E; Cappel C
    Front Immunol; 2019; 10():2816. PubMed ID: 31849984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of interleukin-15 and Flt3-ligand on natural killer cell expansion and activation: umbilical cord vs. adult peripheral blood mononuclear cells.
    Lin SJ; Yang MH; Chao HC; Kuo ML; Huang JL
    Pediatr Allergy Immunol; 2000 Aug; 11(3):168-74. PubMed ID: 10981526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotype and Function of Activated Natural Killer Cells From Patients With Prostate Cancer: Patient-Dependent Responses to Priming and IL-2 Activation.
    Hood SP; Foulds GA; Imrie H; Reeder S; McArdle SEB; Khan M; Pockley AG
    Front Immunol; 2018; 9():3169. PubMed ID: 30761160
    [No Abstract]   [Full Text] [Related]  

  • 30. Stimulation of natural killer activity in peripheral blood lymphocytes of healthy donors and melanoma patients in vitro: synergism between interleukin (IL)-12 and IL-15 or IL-12 and IL-2.
    Seidel MG; Freissmuth M; Pehamberger H; Micksche M
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):382-9. PubMed ID: 9774227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural killer cells stimulated with PM21 particles expand and biodistribute in vivo: Clinical implications for cancer treatment.
    Oyer JL; Pandey V; Igarashi RY; Somanchi SS; Zakari A; Solh M; Lee DA; Altomare DA; Copik AJ
    Cytotherapy; 2016 May; 18(5):653-63. PubMed ID: 27059202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Biological characteristics of cord blood natural killer cells induced and amplified with IL-2 and IL-15].
    Wang J; Sun ZM; Cao LL; Li Q
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):731-5. PubMed ID: 22739191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin (IL)-15 in combination with IL-2, fms-like tyrosine kinase-3 ligand and anti-CD3 significantly enhances umbilical cord blood natural killer (NK) cell and NK-cell subset expansion and NK function.
    Satwani P; van de Ven C; Ayello J; Cairo D; Simpson LL; Baxi L; Cairo MS
    Cytotherapy; 2011 Jul; 13(6):730-8. PubMed ID: 21413839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of exposure to interleukin-21 at various time points on human natural killer cell culture.
    Lim DP; Jang YY; Kim S; Koh SS; Lee JJ; Kim JS; Thi Phan MT; Shin DJ; Shin MG; Lee SH; Yoon M; Kim SK; Yoon JH; Park MH; Cho D
    Cytotherapy; 2014 Oct; 16(10):1419-30. PubMed ID: 24950680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Method for expansion in vitro of CD3-CD56+CD16+NK cells highly purified from human peripheral blood].
    Xiong D; Yang ZG; Li QH; Wu ZC; Lü JT
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1310-5. PubMed ID: 21129283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of cytokines on NK cell activity and activating receptor expression in high-risk cutaneous melanoma patients.
    Martinović KM; Milićević M; Larsen AK; Džodić R; Jurišić V; Konjević G; Vuletić A
    Eur Cytokine Netw; 2019 Dec; 30(4):160-167. PubMed ID: 32096478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of IL-15 in NK cells results in rapid enrichment and selective cytotoxicity of gene-modified effectors that carry a tumor-specific antigen receptor.
    Sahm C; Schönfeld K; Wels WS
    Cancer Immunol Immunother; 2012 Sep; 61(9):1451-61. PubMed ID: 22310931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expansion of human natural killer cells ex vivo].
    Huang QS; Li Q; Huang Y; Shang P; Zhang MJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Dec; 24(12):1167-9. PubMed ID: 19068202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural-killer cell amplification for adoptive leukemia relapse immunotherapy: comparison of three cytokines, IL-2, IL-15, or IL-7 and impact on NKG2D, KIR2DL1, and KIR2DL2 expression.
    Decot V; Voillard L; Latger-Cannard V; Aissi-Rothé L; Perrier P; Stoltz JF; Bensoussan D
    Exp Hematol; 2010 May; 38(5):351-62. PubMed ID: 20172016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21.
    Thangaraj JL; Phan MT; Kweon S; Kim J; Lee JM; Hwang I; Park J; Doh J; Lee SH; Vo MC; Chu TH; Song GY; Ahn SY; Jung SH; Kim HJ; Cho D; Lee JJ
    Cancer Immunol Immunother; 2022 Mar; 71(3):613-625. PubMed ID: 34282497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.